Iron chelation therapy to prevent the manifestations of aceruloplasminemia

Neurology. 2015 Sep 22;85(12):1085-6. doi: 10.1212/WNL.0000000000001956. Epub 2015 Aug 26.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Ceruloplasmin / deficiency*
  • Chelation Therapy / methods*
  • Deferiprone
  • Female
  • Humans
  • Iron
  • Iron Chelating Agents / therapeutic use*
  • Iron Metabolism Disorders / diagnosis
  • Iron Metabolism Disorders / prevention & control*
  • Middle Aged
  • Neurodegenerative Diseases / diagnosis
  • Neurodegenerative Diseases / prevention & control*
  • Pyridones / therapeutic use*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • Iron
  • Ceruloplasmin

Supplementary concepts

  • Familial apoceruloplasmin deficiency